Lymphangitis prevention

Jump to navigation Jump to search

Lymphangitis Microchapters

Home

Overview

Historical Perspective

Classification

Causes

Pathophysiology

Differentiating Lymphangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Case Studies

Case #1

Lymphangitis prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphangitis prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphangitis prevention

CDC on Lymphangitis prevention

Lymphangitis prevention in the news

Blogs on Lymphangitis prevention

Directions to Hospitals Treating Lymphangitis

Risk calculators and risk factors for Lymphangitis prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]

Overview

Lymphangitis being a manifestation of wide concurrently occurring spectrum of manifestations or pathologies. There is no established method of prevention of lymphangitis. Lymphangitis caused by recurrent skin infections due to group A beta-hemolytic streptococci can be prevented by prophylactic administration of antibiotics can reduce the risk of these skin infections complicating into lymphangitis.

Primary prevention

  • There is no established primary prevention for lymphangitis
  • Lymphangitis caused by recurrent skin infections due to group A beta-hemolytic streptococci can be prevented by prophylactic administration of antibiotics can reduce the risk of these skin infections complicating into lymphangitis.[1]

References

  1. Moran GJ, Abrahamian FM, Lovecchio F, Talan DA (2013). "Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines". J Emerg Med. 44 (6): e397–412. doi:10.1016/j.jemermed.2012.11.050. PMID 23466022.